Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

SELL
$5.97 - $10.36 $56,715 - $98,420
-9,500 Reduced 15.7%
51,000 $500,000
Q3 2023

Oct 26, 2023

SELL
$8.23 - $13.93 $244,431 - $413,721
-29,700 Reduced 32.93%
60,500 $505,000
Q2 2023

Jul 31, 2023

SELL
$9.97 - $14.05 $18,943 - $26,695
-1,900 Reduced 2.06%
90,200 $1.2 Million
Q1 2023

Aug 02, 2023

BUY
$7.94 - $12.02 $15,086 - $22,838
1,900 Added 2.11%
92,100 $1.07 Million
Q1 2023

Apr 27, 2023

BUY
$7.94 - $12.02 $513,718 - $777,694
64,700 Added 236.13%
92,100 $1.07 Million
Q4 2022

Jan 26, 2023

BUY
$5.67 - $11.2 $138,915 - $274,400
24,500 Added 844.83%
27,400 $224,000
Q3 2022

Oct 27, 2022

BUY
$3.93 - $8.57 $11,397 - $24,853
2,900 New
2,900 $16,000
Q1 2022

Apr 21, 2022

SELL
$8.43 - $20.9 $111,276 - $275,880
-13,200 Closed
0 $0
Q4 2021

Jan 24, 2022

SELL
$19.26 - $30.08 $142,524 - $222,592
-7,400 Reduced 35.92%
13,200 $270,000
Q3 2021

Oct 22, 2021

SELL
$24.86 - $35.02 $333,124 - $469,268
-13,400 Reduced 39.41%
20,600 $526,000
Q2 2021

Jul 26, 2021

SELL
$22.3 - $36.02 $693,530 - $1.12 Million
-31,100 Reduced 47.77%
34,000 $1.19 Million
Q1 2021

Apr 23, 2021

SELL
$26.38 - $51.15 $176,746 - $342,705
-6,700 Reduced 9.33%
65,100 $2.17 Million
Q4 2020

Jan 25, 2021

SELL
$10.5 - $28.5 $168,000 - $456,000
-16,000 Reduced 18.22%
71,800 $1.86 Million
Q3 2020

Dec 14, 2020

BUY
$3.61 - $9.87 $225,625 - $616,875
62,500 Added 247.04%
87,800 $866,000
Q2 2020

Jul 23, 2020

BUY
$2.65 - $4.03 $67,045 - $101,959
25,300 New
25,300 $87,000
Q3 2019

Oct 21, 2019

SELL
$4.99 - $6.16 $236,027 - $291,368
-47,300 Closed
0 $0
Q2 2019

Jul 25, 2019

BUY
$5.92 - $7.41 $19,536 - $24,453
3,300 Added 7.5%
47,300 $286,000
Q4 2018

Jan 23, 2019

BUY
$3.99 - $7.82 $175,560 - $344,080
44,000 New
44,000 $325,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.